Journals / Eastern Journal of Medicine / 2018 / Cilt: 23 - Sayı: 2

Myoinositol causes myometrial contractions in isolated non-pregnant rat myometrium

Pages
65–70
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We demonstrated for the first time that myoinositol causes contraction in myometrium of nonpregnant rat uterus and it uses the extracellular calcium for contraction.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:We aimed to investigate myoinositol effect on contractility of rat uterus in vitro and its mechanism of action.
📊
Key Findings & Data:After the cessation of spontaneous contractions, 5?M, 50 ?M and 500 ?M of myoinositol and 20?M folic acid were applied to each 7 strips and contractions were again enrolled.
💡
Conclusion & Impact:We demonstrated for the first time that myoinositol causes contraction in myometrium of nonpregnant rat uterus and it uses the extracellular calcium for contraction.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

We aimed to investigate myoinositol effect on contractility of rat uterus in vitro and its mechanism of action. In a standard organ bath spontaneous contractions were recorded. After the cessation of spontaneous contractions, 5?M, 50 ?M and 500 ?M of myoinositol and 20?M folic acid were applied to each 7 strips and contractions were again enrolled. Same procedures were also repeated in calcium free solution. Real Time Polymerase Chain Reaction (RT -PCR) analysis of ion channels were done only for 50 ?M myoinositol which corresponds to the treatment dose. It is demonstrated that in all doses increase in frequency and amplitude of contractions were statistically significant. Any contraction was not observed in calcium free solution which demonstrated us that myoinositol uses extracellular calcium for contraction. It is also demonstrated that folic acid does not cause contraction in non pregnant rat uterine smooth muscle cells. Expression of Transient receptor potential cation channel, subfamily M, member 2 (TRPM2) and Transi ent receptor potential cation channel, subfamily V, member 1 (TRPV1) channels significantly decreased after application of myoinositol (p=0.0 1, for both) whereas expression of Transient receptor potential cation channel, subfamily M, member 7 (TRPM7) and C alcium channel, voltage-dependent, N type, alpha 1B subunit (CACNA1B) channels did not change significantly when compared to control (for both). We demonstrated for the first time that myoinositol causes contraction in myometrium of nonpregnant rat uterus and it uses the extracellular calcium for contraction.

🔖

Cite This Article

KAVAK, E. Ç., KAÇAR, E., KAVAK, S. B., BULMUŞ, Ö., SERHATLIOĞLU, İ., TEKTEMUR, A. (2018). Myoinositol causes myometrial contractions in isolated non-pregnant rat myometrium. Eastern Journal of Medicine, Cilt: 23 - Sayı: 2, 65–70. https://ajindex.com/articles/199486

References (16)

  1. Legro RS, Finegood D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1998; 83(8): 2694-2698
  2. Dinicola S, Chiu TT, Unfer V, Carlomagno G, Bizzarri M. The rationale of the myo-inositol and D-chiro-inositol combined treatment for polycystic ovary syndrome. J Clin Pharmacol 2014; 54(10): 1079-1092
  3. Karen A, Richard AA, Stephen BS. Phosphatidylinositol and inositol phosphate metabolism. Cell Sci 2001; 114(12): 2207-2208
  4. Clements RS Jr, Darnell B. Myo-inositol content of common foods: development of a high-myoinositol diet. Am J Clin Nutr 1980; 33(9): 1954- 1967
  5. Maurizio N, Raffaella P. Combined treatment with myo-Inositol and selenium ensures euthyroidism in subclinical hypothyroidism patients with autoimmune thyroiditis. J Thyroid Res 2013; Article ID 424163
  6. Downes CP. The cellular functions of myoinositol. Biochem Soc Trans 1989; 17(2): 259- 268
  7. Downes CP, Macphee CH. Myo-inositol metabolites as cellular signals. Eur J Biochem 1990; 193(1): 1-18
  8. Greene ND, Stanier P, Copp AJ. Genetics of human neural tube defects. Hum Mol Genet 2009; 18(R2): R113-129
  9. Bizzarri M, Carlomagno G. Inositol: history of an effective therapy for Polycystic Ovary Syndrome. Eur Rev Med Pharmacol Sci 2014; 18(13): 1896-1903
  10. Colodny L, Hoffman RL. Inositol-clinical applications for exogenous use. Altern Med Rev 1998; 3(6): 432-447
  11. Nilius B, Owsianik G. The transient receptor potential family of ion channels. Genome Biol 2011; 12(3): 218-220
  12. Oancea E, Vriens J, Brauchi S, Jun J, Splawski I, Clapham DE. TRPM1 forms ion channels associated with melanin content in melanocytes. Sci Signal 2009; 2(70): ra21
  13. Lange I, Yamamoto S, Partida-Sanchez S, Mori Y, Fleig A, Penner R. TRPM2 functions as a lysosomal Ca2+-release channel in beta cells. Sci Signal 2009; 2(71): ra23
  14. Turner H, Fleig A, Stokes A, Kinet JP, Penner R. Discrimination of intracellular calcium store subcompartments using TRPV1 (transient receptor potential channel, vanilloid subfamily member) release channel activity. Biochem J 2003; 371(Pt 2): 341-50
  15. Hendrics CH. A new technique for the study of motility in the non-pregnancy human uterus. J Obstet Gynaecol Br Commonw 1964; 71: 712- 715
  16. Leyendecker G, Kunz G, Wildt L, Beil D, Deininger H. Uterine hyperperistalsis and dysperistalsis as dysfunctions of the mechanism of rapid sperm transport in patients with endome